A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

2.1K views

⸱

DOI:

10.3791/64615

⸱

October 11th, 2022

 ,  ,  ,  ,  ,  , 

In This Article

Summary

The present protocol describes high-frequency ultrasonography for visualizing the entire mouse thyroid gland and monitoring the growth of anaplastic thyroid carcinoma.

Abstract

Anaplastic thyroid carcinoma (ATC) is associated with a poor prognosis and short median survival time, but no effective treatment improves the outcomes significantly. Genetically engineered murine models that mimic ATC's progression may help researchers to study treatments for this disease. Crossing three different genotypes of mice, a TPO-cre/ERT2; BrafCA/wt; Trp53Δex2-10/Δex2-10 transgenic ATC model was developed. The ATC murine model was induced by an intraperitoneal injection of tamoxifen with overexpression of BrafV600E and deletion of Trp53, and the tumors were generated within about 1 month. High-resolution ultrasound was applied to investigate the tumor initiation and progression, and the dynamic growth curve was obtained by measuring the tumor sizes. Compared to magnetic resonance imaging (MRI) and computed tomography scanning, ultrasound has advantages in observing the ATC murine model, such as being noninvasive, portable, in real-time, and without radiation exposure. High-resolution ultrasound is suitable for dynamic and multiple measurements. However, ultrasonographic examination of the thyroid in mice requires relevant anatomical knowledge and experience. This article provides a detailed procedure for utilizing high-resolution ultrasound to scan tumors in the transgenic ATC model. Meanwhile, ultrasonic parameter adjustment, ultrasound scanning skills, anesthesia and recovery of the animals, and other elements that need attention during the process are listed.

Introduction

Although anaplastic thyroid carcinoma (ATC) accounts for fewer than 2% of thyroid cancers, it causes more than 50% of thyroid cancer-related deaths annually. The median survival time after diagnosis with ATC is only about 6 months, and no treatments are available that significantly improve survival1,2.

The rarity of ATC has hampered the research studying how the disease begins and aggressively progresses. Genetically engineered mouse models that mimic the disease have recently become available, which provide insights into the disease and its responses to possible treatments

Access restricted. Please log in or start a trial to view this content.

Protocol

The present study was performed with approval from the Animal Care and Use Committee of Sichuan University. TPO-cre/ERT2; BrafCA/wt; Trp53Δex2-10/Δex2-10 transgenic mice10 were used in this study (see Table of Materials). The protocol steps can be modified for different animal species if necessary. Twelve mice, including six females and six males, with a mean age of 93 days, were used here.

1. Experimental preparation

  1. Turn on the ultrasonography system (see Table of Materials) and create a new folder for ....

Access restricted. Please log in or start a trial to view this content.

Results

The average right ATC size at the beginning of the study was 4.867 mm2, and the average left ATC size was 5.189 mm2. On the fourth measurement, the average right ATC size had grown to 11.844 mm2, while the tumor size of the left lobe had grown to 9.280 mm2. The total ATC size increased from 10.057 mm2 to 15.843 mm2. In the later stage of the study, the ATC grew rapidly. In terms of the mouse labeled "P92" (Table 1), the tumor size on the f.......

Access restricted. Please log in or start a trial to view this content.

Discussion

This protocol uses high-resolution ultrasonography to analyze orthotopic ATC tumors in a genetically engineered mouse model. The transgenic model, with a genotype of TPO-cre/ERT2; BrafCA/wt; Trp53Δex2-10/Δex2-10, was developed in our laboratory. The animals overexpress BrafV600E and lack Trp53; injecting the animals intraperitoneally with tamoxifen leads to tumor growth after approximately 1 month10. The tumors grow rapidly and reach a m.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have no conflicts of interest to declare.

Acknowledgements

This research received no specific grant from public, commercial, or not-for-profit funding agencies.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Adhesive tapeWinner
Anesthesia systemRWDlifescience
Brafflox/wt miceCollaboration with Institute of Life Science, eBond Pharmaceutical Technology Ltd, Chengdu, China
Chamber for anesthesia inductionRWDlifescience
Cotton swabsWinner
Depilatory creamVeet
Electric heating blanketPetbee
Isoflurane vaporizerRWDlifescience
Medical glovesWinner
Paper towelsBreezeB914JY
TPO-cre/ERT2 miceCollaboration with Institute of Life Science, eBond Pharmaceutical Technology Ltd, Chengdu, China
Trp53flox/wt miceCollaboration with Institute of Life Science, eBond Pharmaceutical Technology Ltd, Chengdu, China
Ultrasound gelKepplerKL-250
Ultrasound machineVisualSonicsVevo 3100

References

  1. Maniakas, A., et al. Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000-2019. JAMA Oncology. 6 (9), 1397-1404 (2020).
  2. Molinaro, E., et al. Anaplastic thyroid carcinoma: From....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Anaplastic Thyroid CarcinomaGenetically Engineered MiceTumor MonitoringUltrasound ImagingTumor Size MeasurementTransgenic Mouse ModelB Mode UltrasoundTumor Progression Analysis